Synteract®, a Syneos Health® company, is a leading full-service CRO focused on the emerging biopharma segment. The Company’s multidisciplinary teams support biotech and pharmaceutical companies across all phases of drug development, providing deep expertise in oncology, dermatology, general medicine, infectious disease and vaccines, neuroscience, pediatrics, and rare and orphan diseases.

Biotechnology

Synteract

Frank Santoro

Martina Kröner

Synteract's CEO and Executive Team includes Steve Powell and 5 others.

CEO and Executive Team

About

Team members

Other teams at Synteract

Leadership Team